Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Black patients less likely to receive added, higher dose meds to control blood pressure
Categories: Scientific Conferences & Meetings
|
Published: November 09, 2020

Black patients less likely to receive added, higher dose meds to control blood pressure

American Heart Association Scientific Sessions 2020, Presentation MP269
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Blood Pressure Medication

copyright American Heart Association

Download (339.8 kB)
Blood Pressure Medication

Blood Pressure Medication

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (339.8 kB) File Permalink

Scientific Sessions 2020

American Heart Association Scientific Sessions 2020 logo - One World. Together for Science. Now a 5-Day Virtual Experience! November 13-17, 2020.

copyright American Heart Association 2020

Download (32.5 kB)
Scientific Sessions 2020

Scientific Sessions 2020

American Heart Association Scientific Sessions 2020 logo - One World. Together for Science. Now a 5-Day Virtual Experience! November 13-17, 2020.

copyright American Heart Association 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (32.5 kB) File Permalink
  • Blood Pressure Medication
  • Scientific Sessions 2020

Related Video

Previous Slide Next Slide

Dr. Elkind-SS20 MP269-Disparities in BP treatment

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020

Download (55.1 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Elkind-SS20 MP269-Disparities in BP treatment

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (55.1 MB) File Permalink

Dr. Elkind-SS20 MP269-Don't stop BP meds

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020

Download (39.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Elkind-SS20 MP269-Don't stop BP meds

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (39.4 MB) File Permalink

Dr. Elkind-SS20 MP269-Prescribing practices

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020

Download (33.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Elkind-SS20 MP269-Prescribing practices

American Heart Association President, Mitchell S. V. Elkind, M.D., MS, FAHA, FAAN, professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons and attending neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.

Offering perspective on AHA Scientific Sessions 2020 Presentation MP269 - News Release

Video transcript (txt)

copyright American Heart Association 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (33.7 MB) File Permalink
  • Dr. Elkind-SS20 MP269-Disparities in BP treatment
  • Dr. Elkind-SS20 MP269-Don't stop BP meds
  • Dr. Elkind-SS20 MP269-Prescribing practices
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED